Showing results (81-90 of 91) with videos related to
Sort By:
Pageof 10
The American Journal of Physiology|February 1, 1996
Postmarathon paradox: insulin resistance in the face of glycogen depletionJ A Tuominen, P Ebeling, R Bourey, et al.Diabetologia|January 29, 2000
Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetesP Ebeling, A M Teppo, H A Koistinen, et al.Leukemia|August 26, 2006
Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression statusA Hüttmann, L Klein-Hitpass, J Thomale, et al.Diabetologia|December 24, 2004
Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathyM Saraheimo, C Forsblom, T K Hansen, et al.Neurology|February 1, 1996
Immune brachial plexus neuropathy: suggestive evidence for an inflammatory-immune pathogenesisG A Suarez, C Giannini, E P Bosch, et al.European Journal of Haematology|December 23, 2004
Thalidomide in combination with vincristine, epirubicin and dexamethasone (VED) for previously untreated patients with multiple myelomaP Schütt, P Ebeling, U Buttkereit, et al.Journal of Cancer Research and Clinical Oncology|September 2, 2008
Anthracyline-reduced sequential combination chemotherapy for younger patients with good-prognosis aggressive B-cell non-Hodgkin's lymphomaP Schütt, K Zimmermann, C Derks, et al.European Journal of Clinical Investigation|April 12, 2000
Subcutaneous adipose tissue expression of tumour necrosis factor-alpha is not associated with whole body insulin resistance in obese nondiabetic or in type-2 diabetic subjectsH A Koistinen, J P Bastard, E Dusserre, et al.The Journal of Antimicrobial Chemotherapy|November 26, 2005
Caspofungin treatment in severely ill, immunocompromised patients: a case-documentation study of 118 patientsA Glasmacher, O A Cornely, K Orlopp, et al.Contemporary Clinical Trials|April 18, 2016
The D-Health Trial: A randomized trial of vitamin D for prevention of mortality and cancerR E Neale, B K Armstrong, C Baxter, et al.Pageof 10